Professor Peter Flatt holds a BSc Hons and PhD from Aston University. He was a Research Fellow at the University of Uppsala, Sweden (1978-80) before taking up an academic appointment at Surrey University in 1980 . He is currently Professor of Biomedical Sciences at Ulster University, a position that he has held since 1989.
Professor Flatt is Head of the Diabetes Research Group, having served as Director of Biomedical Sciences Research Centre (1992-94) and Head of the School of Biomedical Sciences (1994-97).
He is author of over 500 full scientific peer-reviewed papers (h-index 55) on various aspects of diabetes and editor of four major diabetes research texts including New Antidiabetic Drugs (Smith-Gordon, 1990) and Nutrient Regulation of Insulin Secretion (Portland Press, 1992).
Professor Flatt is founding Chairman (1991-) of the Islet Study Group of the European Association for the Study of Diabetes (EASD), member of the EASD Council (1997-01), Scientific Secretary and Committee Member of Diabetes UK (1991-97; 2001-04) and a member of the Grants Review Board of the Juvenile Diabetes Federation International (1996-99).
He is a recipient of the Mary Jane Kugal Award (1999) of Juvenile Diabetes Federation International, Biochemical Society Medal (2005), and was elected to membership of Royal Irish Academy (2006), Ulster University Distinguished Senior Research Fellowship (2006) and Diabetes UK Dorothy Hodgkin Award Lecturer (2008). Patent holder, Academic co-founder and Chief Scientific Officer/Director of Diabetica Ltd.
|Novel fatty acid receptors in islet cells as therapeutic targets for diabetes Funded PhD Opportunity||Friday 7 February 2020||View Details|
|Targeted exendin/apelin hybrid peptides for diabetes and obesity therapy. Funded PhD Opportunity||Friday 7 February 2020||View Details|
|Utility of combined GLP-1 and neurotensin receptor signalling, and/or related hybrid peptides, for type 2 diabetes therapy Self-funded PhD Opportunity||Tuesday 1 September 2020||View Details|
|Novel amphibian skin peptide-analogues for the treatment of type-2 diabetes Self-funded PhD Opportunity||Friday 18 September 2020||View Details|
|Regulation of glucose metabolism by incretin signalling Funded PhD Opportunity||Friday 7 February 2020||View Details|
|Modulation of pancreatic beta-cell Neuropeptide Y (NPY) receptors as a novel therapeutic option for diabetes Funded PhD Opportunity||Friday 7 February 2020||View Details|
|Isolation and characterization of phytochemicals with insulin-releasing or glucose lowering effects for the treatment of type-2 diabetes Self-funded PhD Opportunity||Friday 18 September 2020||View Details|